India gives go-ahead to domestic trial of Russia’s pioneering ‘Sputnik V’ Covid-19 vaccine

India’s vaccines regulator

India’s vaccines regulator has given the green light for a clinical study of the Russia-developed Covid-19 vaccine. Similar trials of the formulation are underway in Russia itself and in some other nations.

The Drugs Controller General of India (DCGI), a department in India’s drug regulator that is responsible for licensing vaccines, has given its approval for a domestic clinical study of the Russian candidate vaccine dubbed “Sputnik V,” Indian and Russian partners have announced in a joint statement. The “multi-center and randomized controlled study” will be conducted by Dr Reddy’s Laboratories, a Hyderabad-based pharmaceutical giant.

Continue reading